Process for the preparation of 2-(cyclohexylmethyl)-N-{2- [(2S)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4tetrahydroisoquinoline-7-sulfonamide

Details for Australian Patent Application No. 2011223560 (hide)

Owner Sanofi

Inventors Elenbaas, Steven

Agent Watermark

Pub. Number AU-A-2011223560

PCT Pub. Number WO2011/109675

Priority 61/311,069 05.03.10 US; 1059750 25.11.10 FR

Filing date 4 March 2011

Wipo publication date 9 September 2011

International Classifications

C07D 217/04 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/109675 Priority application(s): WO2011/109675

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223563-Modulation of intracellular signaling

2011223559-Evaluating noise and excess current on a power line